Abstract
This study systematically reviewed the clinical practice guidelines (CPGs) for depression in children and adolescents and assessed the quality and recommendation consistency of those CPGs. Evidence mapping was presented to illustrate the research trends and identify gaps to guide future research. Literature on CPGs for depression was systematically collected from PubMed, Embase, Web of Science, guideline databases, and psychiatric association/ society websites. The basic information, recommendations, methodological quality, and reporting quality of CPGs were extracted, and the supporting evidence strength for the included CPGs was analyzed in Excel. Four appraisers independently assessed the eligible CPGs using AGREE II instrument and the RIGHT checklist. All recommendations from the CPGs were summarized and analyzed, and the evidence mapping bubble charts were plotted in Excel. After excluding 15,184 records, 12 depression CPGs were eventually proved eligible, six of which were of high quality and six medium quality. A total of 39 major recommendations were summarized, 35 of which were supported by high-quality CPGs. Although direct comparisons are challenging due to differences in grading schemes and research quality, most CPGs share many pivotal recommendations that can help guide clinical practice. However, the evidence for some clinical problems is still lacking. Thus, more research is necessary on the screening and treatment of children and adolescents to put forward more evidence-based and high-quality recommendations.
Similar content being viewed by others
Availability of data and materials
Under request.
Code availability
Not applicable.
References
Ryan ND (2005) Treatment of depression in children and adolescents. Lancet 366:933–940. https://doi.org/10.1016/S0140-6736(05)67321-7
Thapar A, Collishaw S, Pine DS, Thapar AK (2012) Depression in adolescence. Lancet 379:1056–1067. https://doi.org/10.1016/S0140-6736(11)60871-4
Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa TA, Weisz JR, Li X, Cuijpers P, Coghill D, Xiang Y, Hetrick SE, Leucht S, Qin M, Barth J, Ravindran AV, Yang L, Curry J, Fan L, Silva SG, Cipriani A, Xie P (2020) Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry 7:581–601. https://doi.org/10.1016/S2215-0366(20)30137-1
Grover S, Avasthi A (2019) Clinical Practice Guidelines for the management of depression in children and adolescents. Indian J Psychiatry 61:226–240. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_563_18
Cassano P, Fava M (2002) Depression and public health: an overview. J Psychosom Res 53:849–857. https://doi.org/10.1016/s0022-3999(02)00304-5
McCarron RM, Vanderlip ER, Rado J (2016) Depression. Ann Intern Med 165:ITC4964. https://doi.org/10.7326/AITC201610040
Murad MH (2017) Clinical Practice Guidelines: a primer on development and dissemination. Mayo Clin Proc 92:423–433. https://doi.org/10.1016/j.mayocp.2017.01.001
Institute of Medicine (US) Committee to Advise the Public Health Service on Clinical Practice G. In: Field MJ, Lohr KN eds (1990) Clinical Practice Guidelines: directions for a new program. National Academies Press, Washington
Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J (1999) Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 318:527–530. https://doi.org/10.1136/bmj.318.7182.527
Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, Whitty P, Eccles MP, Matowe L, Shirran L, Wensing M, Dijkstra R, Donaldson C (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 8:1–72. https://doi.org/10.3310/hta8060 (iii–iv)
Ge L, Tian JH, Li YN, Pan JX, Li G, Wei D, Xing X, Pan B, Chen YL, Song FJ, Yang KH (2018) Association between prospective registration and overall reporting and methodological quality of systematic reviews: a meta-epidemiological study. J Clin Epidemiol 93:45–55. https://doi.org/10.1016/j.jclinepi.2017.10.012
Erickson J, Sadeghirad B, Lytvyn L, Slavin J, Johnston BC (2017) The scientific basis of guideline recommendations on sugar intake: a systematic review. Ann Intern Med 166:257–267. https://doi.org/10.7326/M16-2020
Snilstveit B, Vojtkova M, Bhavsar A, Stevenson J, Gaarder M (2016) Evidence and Gap Maps: a tool for promoting evidence informed policy and strategic research agendas. J Clin Epidemiol 79:120–129. https://doi.org/10.1016/j.jclinepi.2016.05.015
Bragge P, Clavisi O, Turner T, Tavender E, Collie A, Gruen RL (2011) The global evidence mapping initiative: scoping research in broad topic areas. BMC Med Res Methodol 11:92. https://doi.org/10.1186/1471-2288-11-92
Akl EA, Haddaway NR, Rada G, Lotfi T (2020) Future of Evidence Ecosystem Series: evidence synthesis 2.0: when systematic, scoping, rapid, living, and overviews of reviews come together. J Clin Epidemiol 123:162–165. https://doi.org/10.1016/j.jclinepi.2020.01.025
Miake-Lye IM, Hempel S, Shanman R, Shekelle PG (2016) What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and products. Syst Rev 5:28. https://doi.org/10.1186/s13643-016-0204-x
Lam J, Howard BE, Thayer K, Shah RR (2019) Low-calorie sweeteners and health outcomes: a demonstration of rapid evidence mapping (rEM). Environ Int 123:451–458. https://doi.org/10.1016/j.envint.2018.11.070
Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71
Johnston A, Kelly SE, Hsieh SC, Skidmore B, Wells GA (2019) Systematic reviews of clinical practice guidelines: a methodological guide. J Clin Epidemiol 108:64–76. https://doi.org/10.1016/j.jclinepi.2018.11.030
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L, AGREE Next Steps Consortium (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 182:E839-842. https://doi.org/10.1503/cmaj.090449
Chen Y, Yang K, Marušic A, Qaseem A, Meerpohl JJ, Flottorp S, Akl EA, Schünemann HJ, Chan ES, Falck-Ytter Y, Ahmed F, Barber S, Chen C, Zhang M, Xu B, Tian J, Song F, Shang H, Tang K, Wang Q, Norris SL, RIGHT (Reporting Items for Practice Guidelines in Healthcare) Working Group (2017) A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med 166:128–132. https://doi.org/10.7326/M16-1565
Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420–428. https://doi.org/10.1037//0033-2909.86.2.420
Li X, Yu X, Xie Y, Feng Z, Ma Y, Chen Y, Li J (2020) Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis. Ann Transl Med 8:1405. https://doi.org/10.21037/atm-20-3200
Kramer MS, Feinstein AR (1981) Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther 29:111–123. https://doi.org/10.1038/clpt.1981.18
Birmaher B, Brent D (2007) Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 46:1503–1526. https://doi.org/10.1097/chi.0b013e318145ae1c
New Zealand Guidelines Group (2008) Identification of common mental disorders and management of depression in primary care. An Evidence-based Best Practice Guideline. NZGG. https://www.health.govt.nz/publication/identification-common-mental-disorders-and-management-depression-primary-care
Singapore Ministry of Health (2012) Depression: MOH clinical practice guidelines. MOH. https://www.moh.gov.sg/docs/librariesprovider4/guidelines/depressioncpg_r14_final0147b0b18c63417ebd084c2d613dc83d.pdf
Malhi GS, Bassett D, Boyce P, Bryant R, Fitzgerald PB, Fritz K, Hopwood M, Lyndon B, Mulder R, Murray G, Porter R, Singh AB (2015) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 49:1087–1206. https://doi.org/10.1177/0004867415617657
Siu AL, US Preventive Services Task Force (2016) Screening for Depression in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. Pediatrics 137:e20154467. https://doi.org/10.1542/peds.2015-4467
Macqueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Lieshout RJ, Kennedy SH, Lam RW, Milev RV, Parikh SV, Ravindran AV, CANMAT Depression Work Group (2016) Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 6. Special populations: youth, women, and the elderly. Can J Psychiatry 61:588–603. https://doi.org/10.1177/0706743716659276
The National Centre of Excellence in Youth Mental Health (2017) Treating depression in young people-Guidance, resources and tools for assessment and management. Orygen. https://www.orygen.org.au/Training/Resources/Depression/Clinical-practice-points/Treating-depression-in-yp
Zuckerbrot RA, Cheung A, Jensen PS, Stein REK, Laraque D, GLAD-PC STEERING GROUP (2018) Guidelines for adolescent depression in primary care (GLAD-PC): Part I. Practice preparation, identification, assessment, and initial management. Pediatrics 141:e20174081. https://doi.org/10.1542/peds.2017-4081
Kaiser Permanente (2018) Adult and adolescent depression screening, diagnosis, and treatment guideline. KP
American Psychological Association (2019) Clinical practice guideline for the treatment of depression across three age cohorts American Psychological Association Guideline Development Panel for the treatment of depressive disorders. APA. https://www.apa.org/depression-guideline
National Institute for Health and Care Excellence (2019) Depression in children and young people identification and management (NG134). NICE. https://www.nice.org.uk/guidance/ng134
Shen WQ, Yao L, Wang XQ, Hu Y, Bian ZX (2018) Quality assessment of cancer cachexia clinical practice guidelines. Cancer Treat Rev 70:9–15. https://doi.org/10.1016/j.ctrv.2018.07.008
Madera Anaya MV, Franco JV, Merchán-Galvis ÁM, Gallardo CR, Bonfill Cosp X (2018) Quality assessment of clinical practice guidelines on treatments for oral cancer. Cancer Treat Rev 65:47–53. https://doi.org/10.1016/j.ctrv.2018.03.001
Jiang M, Guan WJ, Fang ZF et al (2016) A critical review of the quality of cough clinical practice guidelines. Chest 150(4):777–788. https://doi.org/10.1016/j.chest.2016.04.028
Lytras T, Bonovas S, Chronis C et al (2014) Occupational asthma guidelines: a systematic quality appraisal using the AGREE II instrument. Occup Environ Med 71(2):81–86. https://doi.org/10.1136/oemed-2013-101656
Fuentes Padilla P, Martínez G, Vernooij RWM, Cosp XB, Alonso-Coello P (2016) Nutrition in critically ill adults: a systematic quality assessment of clinical practice guidelines. Clin Nutr 35(6):1219–1225. https://doi.org/10.1016/j.clnu.2016.03.005
Knight S, Takagi M, Fisher E, Anderson V, Lannin NA, Tavender E, Scheinberg A (2019) A systematic critical appraisal of evidence-based clinical practice guidelines for the rehabilitation of children with moderate or severe acquired brain injury. Arch Phys Med Rehabil 100(4):711–723. https://doi.org/10.1016/j.apmr.2018.05.031
Zafra-Tanaka JH, Goicochea-Lugo S, Villarreal-Zegarra D, Taype-Rondan A (2019) Characteristics and quality of clinical practice guidelines for depression in adults: a scoping review. BMC Psychiatry 19(1):76. https://doi.org/10.1186/s12888-019-2057-z
Zhao Y, Li Y, Li J, Song W, Zhao J, Xu Y, Zhai Y, Xu S (2020) Reporting quality of chronic kidney disease practice guidelines according to the RIGHT statement: a systematic analysis. Ther Adv Chronic Dis 11(20406223):20922017. https://doi.org/10.1177/2040622320922017
Yang Y, Lu J, Ma Y, Xi C, Kang J, Zhang Q, Jia X, Liu K, Du S, Kocher F, Seeber A, Gridelli C, Provencio M, Seki N, Tomita Y, Zhang X (2021) Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist. Transl Lung Cancer Res 10(6):2588–2602. https://doi.org/10.21037/tlcr21-405
Yao X, Ma J, Wang Q, Kanters D, Ali MU, Florez ID (2020) A Comparison of AGREE and RIGHT: which clinical practice guideline reporting checklist should be followed by guideline developers? J Gen Intern Med 35(3):894–898. https://doi.org/10.1007/s11606-019-05508-3
Zhao S, Cao J, Shi Q, Wang Z, Estill J, Lu S, Luo X, Zhao J, Zhang H, Wang J, Wang Q, Xun Y, Zhang J, Lv M, Liu Y, Nie X, Wang L, Zhang X, Li W, Liu E, Wang X, Chen Y (2020) A quality evaluation of guidelines on five different viruses causing public health emergencies of international concern. Ann Transl Med 8(7):500. https://doi.org/10.21037/atm.2020.03.130
McCarron RM, Vanderlip ER, Rado J (2016) Depression. Ann Intern Med 165(7):ITC49–ITC64. https://doi.org/10.7326/AITC201610040
Forman-Hoffman VL, Viswanathan M (2018) Screening for depression in pediatric primary care. Curr Psychiatry Rep 20(8):62. https://doi.org/10.1007/s11920-018-0926-7
Maurer DM, Raymond TJ, Davis BN (2018) Depression: screening and diagnosis. Am Fam Physician 98(8):508–515. https://pubmed.ncbi.nlm.nih.gov/30277728/
Malhi GS, Mann JJ (2018) Depression. Lancet 392(10161):2299–2312. https://doi.org/10.1016/S01406736(18)31948-2
Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ 365:l1781. https://doi.org/10.1136/bmj.l1781
Lakkis NA, Mahmassani DM (2015) Screening instruments for depression in primary care: a concise review for clinicians. Postgrad Med 127(1):99–106. https://doi.org/10.1080/00325481.2015.992721
Krause KR, Chung S, Adewuya AO, Albano AM, Babins-Wagner R, Birkinshaw L, Brann P, Creswell C, Delaney K, Falissard B, Forrest CB, Hudson JL, Ishikawa SI, Khatwani M, Kieling C, Krause J, Malik K, Martínez V, Mughal F, Ollendick TH, Ong SH, Patton GC, Ravens-Sieberer U, Szatmari P, Thomas E, Walters L, Young B, Zhao Y, Wolpert M (2021) International consensus on a standard set of outcome measures for child and youth anxiety, depression, obsessive-compulsive disorder, and post-traumatic stress disorder. Lancet Psychiatry 8(1):76–86. https://doi.org/10.1016/S2215-0366(20)30356-4
Obbarius A, van Maasakkers L, Baer L, Clark DM, Crocker AG, de Beurs E, Emmelkamp PMG, Furukawa TA, Hedman-Lagerlöf E, Kangas M, Langford L, Lesage A, Mwesigire DM, Nolte S, Patel V, Pilkonis PA, Pincus HA, Reis RA, Rojas G, Sherbourne C, Smithson D, Stowell C, Woolaway-Bickel K, Rose M (2017) Standardization of health outcomes assessment for depression and anxiety: recommendations from the ICHOM Depression and Anxiety Working Group. Qual Life Res 26(12):3211–3225. https://doi.org/10.1007/s11136-017-1659-5
Taurines R, Gerlach M, Warnke A, Thome J, Wewetzer C (2011) Pharmacotherapy in depressed children and adolescents. World J Biol Psychiatry 12(Suppl 1):11–15. https://doi.org/10.3109/15622975.2011.600295
Food and Drug Administration (2019) Suicidality in children and adolescents being treated with antidepressant medications. US Food and Drug Administration. https://www.fda.gov/drugs/postmarket-drug-safetyinformation-patients-and-providers/suicidality-children-and-adolescents-being-treated-antidepressantmedications
Food and Drug Administration (2004) Suicidality in children and adolescents being treated with antidepressant medications. US Food and Drug Administration, Silver Spring. http://wayback.archive-it.org/7993/20170113164717; http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm161679.htm
Viswanathan M, Kennedy SM, McKeeman J, Christian R, Coker-Schwimmer M, Cook Middleton J, Bann C, Lux L, Randolph C, Forman-Hoffman V (2020) Treatment of Depression in Children and Adolescents: A Systematic Review [Internet]. Agency for Healthcare Research and Quality (US), Rockville. Report No.: 20-EHC005-EF. https://pubmed.ncbi.nlm.nih.gov/32298061/
Haller H, Anheyer D, Cramer H, Dobos G (2019) Complementary therapies for clinical depression: an overview of systematic reviews. BMJ Open 9(8):e028527. https://doi.org/10.1136/bmjopen-2018-028527
Benson NM, Seiner SJ (2019) Electroconvulsive therapy in children and adolescents: clinical indications and special considerations. Harv Rev Psychiatry 27(6):354–358. https://doi.org/10.1097/HRP.0000000000000236
Sun Y, Gao Y, Chen J, Sun H, Cai YT, Ge L, Li YN, Zhang J, Tian JH (2019) Evidence mapping of recommendations on diagnosis and therapeutic strategies for diabetes foot: an international review of 22 guidelines. Metabolism 100:153956. https://doi.org/10.1016/j.metabol.2019.153956
Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, Phillips B, Lelgemann M, Lethaby A, Bousquet J, Guyatt GH, Schünemann HJ, GRADE Working Group (2009) Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy 64(5):669–677. https://doi.org/10.1111/j.13989995.2009.01973.x
Bennett K, Courtney D, Duda S, Henderson J, Szatmari P (2018) An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depress Anxiety 35(6):530–540. https://doi.org/10.1002/da.22752
Acknowledgements
We have received funding from Gansu Province Science and Technology Planning Project, National Key R&D Program Funded Projects and The Fundamental Research Funds for the Central Universities provided funding for this study. We would like to thank Ya Gao and Yitong Cai for their methodological support and assistance with the final editing of the article.
Funding
This study was funded by Gansu Province Science and Technology Planning Project (Grant/Award Numbers: 20CX4ZA027, 20CX9ZA112); National Key R&D Program Funded Projects (Grant/Award Number: 2019YFC1709805); The Fundamental Research Funds for the Central Universities (Grant/Award Number: 3332020027).
Author information
Authors and Affiliations
Contributions
JH-T and ML-Y carried out the study design, JH-T and JL conducted a literature search. ML-Y, LZ, MM-N, FF-W, YM-C, ZW-S, and YG-Z contributed to the data acquisition and drafted parts of the methods and results sections of the manuscript. ML-Y, LM-C and MY contributed to data interpretation and statistical analysis, and drafted the rest of the manuscript. JH-T and JL supervised and provide mentorship. All authors edited the report and contributed to the revision of the report. All authors reviewed the manuscript, approved the final draft, and agreed to submit it for publication.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yan, M., Chen, L., Yang, M. et al. Evidence mapping of clinical practice guidelines recommendations and quality for depression in children and adolescents. Eur Child Adolesc Psychiatry 32, 2091–2108 (2023). https://doi.org/10.1007/s00787-022-01958-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00787-022-01958-z